Kuala Lumpur, 16 June 2026 – KPJ Healthcare Berhad ("KPJ Healthcare" or "the Group") today held its 33rd Annual General Meeting ("AGM"), highlighting progress under the KPJ Health System ("KPJHS"), underpinned by a strong FY2025 performance and focused on the Group's next phase of growth.

For FY2025, KPJ Healthcare recorded revenue of RM4.26 billion, an increase of 9% from RM3.90 billion in FY2024. Profit before tax rose 6% to RM563 million, while profit after tax increased 10% to RM402 million. The Group also continued delivering value to shareholders through improved returns, a stronger balance sheet and sustained growth in market capitalisation.

Tan Sri Dato' Sri Dr Ismail Haji Bakar, Chairman of KPJ Healthcare said, "FY2025 reflected the continued evolution of KPJ Healthcare beyond a network of hospitals towards a more integrated health system that brings together clinical practice, education, research and innovation. This approach strengthens our ability to deliver high-quality care, develop future healthcare talent and support innovation, while creating sustainable value for patients, communities and shareholders. As we look ahead, we remain focused on ensuring that KPJ continues to grow with purpose, resilience and long-term impact, creating broader access to quality healthcare and delivering meaningful improvements in health outcomes."

Chin Keat Chyuan, President and Managing Director of KPJ Healthcare said, "During FY2025, we made meaningful progress across clinical excellence, talent development and innovation, while strengthening the foundations needed to support the Group's future growth. Our focus now is on scaling these capabilities across the network through system integration, Centres of Excellence and emerging healthcare capabilities such as artificial intelligence, genomics and value-based care, ensuring that we continue delivering better outcomes for patients while creating sustainable long-term value, in line with its Care for Life purpose."

Across the Group, FY2025 saw continued progress in specialised care, healthcare talent development and innovation, reflecting how the KPJ Health System is bringing clinical practice, education, research and innovation closer together.

In April 2025, Damansara Specialist Hospital became the first private hospital in Malaysia to successfully perform the pressurised intraperitoneal aerosol chemotherapy (PIPAC) procedure, a minimally invasive chemotherapy treatment for advanced abdominal cancer.

Key developments during the year included the launch of the Heart and Lung Centre of Excellence at Johor Specialist Hospital, several clinical firsts across the network such as Malaysia's first private-sector Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC) procedure and Deep Brain Stimulation surgery, continued engagement with Mayo Clinic, the expansion of specialised training programmes through KPJ Healthcare University's School of Digital Health and AI Academy, as well as innovation initiatives such as the implementation of a Research Management System, collaboration with the University of Melbourne to support digital health innovation and the development of an AI-powered patient engagement chatbot in collaboration with IBM Malaysia.

**Prof. Dato' Dr Hanafiah Harunarashid**, Chief Medical Director of KPJ Healthcare (fourth from left); **Hoo Ling Lee**, Regional Chief Executive Officer (Central), KPJ Healthcare (fourth from right); **Catherine Lim Tsuey Tyng**, Chief Executive Officer of Tawakkal Specialist Hospital (third from right); **Dr Nurhashim Haron**, Medical Director of Tawakkal Specialist Hospital (second from right) with the medical experts involved, taking a commemorative photo at the launch of KPJ’s first Kidney Transplant Service.

Building on this momentum, the Group has continued advancing its strategic priorities in FY2026, including the launch of the Neuroscience and Stroke Centre of Excellence at Damansara Specialist Hospital 2, the successful completion of a kidney transplant procedure at Tawakkal Specialist Hospital and the signing of a memorandum of understanding with the Royal College of Surgeons of England to further strengthen clinical excellence and healthcare talent development across the KPJ Health System.

**Dr Nik Fawaz Nik Abdul Aziz**, Chief Operating Officer, Group Allied & Retail Health Operations, KPJ Healthcare (seated, second from left) signing the MoU agreement with **Tim Mitchell**, President, Royal College of Surgeons of England (seated, second from right), as witnessed by **Dr Mizarina Dato' Abu Bakar**, Chief Executive Officer, KPJ Healthcare University (seated, left), **Prof. Naeem Soomro**, Council Member, Royal College of Surgeons of England (seated, right) and representatives from the KPJ Group and Royal College of Surgeons of England.

Looking ahead, the Group will continue advancing the KPJ Health System through deeper integration across its network and the expansion of convergence initiatives, while accelerating the development of Centres of Excellence and scaling the adoption of artificial intelligence, genomics and value-based care to support more personalised and outcome-focused healthcare delivery.

As Malaysia's first private integrated Academic Health System, KPJ Healthcare remains committed to translating these efforts into better health outcomes and sustainable value for the communities it serves.

For more information on KPJ Healthcare, visit https://kpjhealth.com.my/.

This content is provided by KPJ Healthcare Berhad

The views expressed here are those of the author/contributor and do not necessarily represent the views of Malaysiakini.

Interested in having your press releases, exclusive interviews, or branded content articles on Malaysiakini? For more information, contact [email protected] or [email protected]